A detailed history of Godsey & Gibb Associates transactions in Davita Inc. stock. As of the latest transaction made, Godsey & Gibb Associates holds 100 shares of DVA stock, worth $14,757. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$14,757
Previous $13,000 23.08%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 18, 2023

BUY
$74.68 - $85.82 $7,468 - $8,582
100 New
100 $8,000
Q2 2022

Jul 25, 2022

BUY
$76.05 - $123.38 $7,605 - $12,338
100 New
100 $8,000
Q4 2021

Feb 15, 2022

SELL
$94.5 - $116.95 $9,450 - $11,695
-100 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$99.98 - $123.89 $9,998 - $12,389
100 New
100 $11,000

Others Institutions Holding DVA

About DAVITA INC.


  • Ticker DVA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 91,300,000
  • Market Cap $13.5B
  • Description
  • DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...
More about DVA
Track This Portfolio

Track Godsey & Gibb Associates Portfolio

Follow Godsey & Gibb Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Godsey & Gibb Associates, based on Form 13F filings with the SEC.

News

Stay updated on Godsey & Gibb Associates with notifications on news.